| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $1.2M | +51.8% |
| SG&A Expense | $2.1M | +150.8% |
| Operating Income | -$3.3M | -103.6% |
| Net Income | -$3.4M | -106.6% |
| EPS (Basic) | $0.23 | +64.3% |
| EPS (Diluted) | $0.23 | +64.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $288K | +88.2% |
| Current Assets | $331K | -21.6% |
| Total Assets | $333K | -21.1% |
| Current Liabilities | $227K | -22.8% |
| Stockholders' Equity | $106K | -17.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$759K | +46.5% |
| Investing Cash Flow | -$2K | — |
| Financing Cash Flow | $896K | -39.3% |